[M5] Optimizing Value Assessment Tools for Coverage and Reimbursement Decisions: Promises and Pitfalls
Pricing: Free for Members and $30 for Non-Members
Course Description
In response to rising costs, health care decision-makers are increasingly looking to value assessment frameworks to evaluate the value of health care treatments. Over time, U.S. payers have increasingly used value assessment tools to inform pricing negotiations and formulary decisions. To help ensure that value assessment tools are used as intended and support optimal patient care, it is important that managed care pharmacy professionals have a comprehensive understanding of different U.S. value assessment tools, methodologies, and their respective strengths and limitations.
This session will review how U.S. payers are integrating value assessment tools in their decision-making and identify opportunities and challenges associated with applying global health technology assessment (HTA) methods to the U.S. health system.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Identify current sources of value assessment information and US-focused value assessment tools.
- Summarize key considerations for applying ex-US HTA approaches to the US health care system.
- Describe how US value assessment tools can be used to inform healthcare payer decision-making.
Faculty
Jessica Hatton, PharmD, BCACP
Associate Vice President, Pharmacy
CareSource
Kimberly Riggs, MPH
Vice President
Cencora
Kimberly Westrich, MA
Director, Value & Access Strategy
Cencora
Moderator
Thomas C. Pomfret, PharmD, MPH, BCPS
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Jessica Hatton Faculty | Disclosed no relevant financial relationships. |
Kimberly Riggs Faculty | Employee: Cencora (formerly Amerisource Bergen/Xcenda) |
Kimberly Westrich Faculty | Employee: Xcenda/AmerisourceBergen, Other, I am an employee of Xcenda. Our parent company, AmerisourceBergen, is a pharmaceutical sourcing and distribution services company |
Amy Lugo Reviewer | Disclosed no relevant financial relationships. |
Brooke Whittington Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
ACPE UAN:0233-0000-23-060-H04-P
Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: November 15, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion
Price
Required Hardware/software
Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities